cross lifespan. Inappropriate behaviors may result from acquiring maladaptive associations between irrelevant information in the environment and important events, such as reward or punishment. Pre-exposure effects are believed to prevent the expression of irrelevant associations. For example, learned irrelevance delays the expression of associations between conditioned (CS) and unconditioned (US) stimuli following their uncorrelated presentation. The neuronal substrates of pre-exposure effects in humans are largely unknown because these effects rapidly attenuate when using traditional pre-exposure paradigms. The latter are therefore incompatible with neuroimaging approaches that require many trial repetitions. Moreover, large methodological differences between animal and human research on pre-exposure effects challenge the presumption of shared neurocognitive substrates, and question the prevalent use of pre-exposure effects in animals to model symptoms of human mental disorders. To overcome these limitations, we combined a ncrease the relative weight of 'CS-no US' associations following 'no US' outcomes, correlated with activity in the basolateral amygdala. By extending previous animal observations to humans, the present study provides a novel approach to foster translational research on pre-exposure effects. OBJECTIVE Several reports in the literature have identified an association between cortisol levels and the presence of chronic pain in conditions such as rheumatoid arthritis, low back pain or whiplash. In contrast, few have examined the association of cortisol and pain in people with osteoarthritis (OA). The purpose of this systematic review was to verify the association between cortisol and pain in the OA population. DESIGN The databases MEDLINE, CINAHL, EMBASE were searched systematically for human studies written in English up to December 2018. Two researchers screened titles and abstracts against predefined inclusion criteria; a third resolved discrepancies. Articles were included if they measured the cortisol levels in adults with pain in the OA population. Methodological quality was assessed using Methodological Index for non-randomized Studies (MINORS) score. RESULTS Seven studies reporting on 415 patients were included in this review. The MINORS scale yielded mean scores of 8.6 of 16 and 17.5 of 24, for the cohort and case-control studies respectively. In general, the studies were of poor quality. A discrepancy of noteworthy associations between cortisol level comparison and pain was found. CONCLUSIONS This study shows that there is a discrepancy in the relationship between cortisol and pain dependent on how and when cortisol is measured. Evidence from three low-quality studies suggest increased cortisol levels in patients with pain but the conclusions have a high risk of bias. It was not possible to make a quantitative analysis comparing the relationship between cortisol and pain in the OA population. Resveratrol, a well-known antioxidant, has been reported to protect mouse metaphase-II (M - II) stage oocytes from vitrification injuries when used as a treatment during a series of vitrification processes. The present study was conducted to investigate whether short-term treatment of post-warm bovine mature oocytes with resveratrol can increase blastocyst formation rate following in vitro fertilization and culture. Bovine denuded M - II oocytes were vitrified-warmed using Cryotop® or nylon mesh (pore size = 37 μm) as a cryodevice. The post-warm oocytes were treated for 2 h with 1 μM resveratrol in recovery culture medium. The resveratrol treatment had no harmful influence on morphological survival and cleavage rate of the oocytes vitrified-warmed with Cryotop® or nylon mesh. In the Cryotop® vitrification series, blastocyst formation rate of resveratrol-treated post-warm oocytes (39.0%) was not significantly different from that of non-treated post-warm oocytes (31.7%). https://www.selleckchem.com/products/mf-438.html However in the nylon mesh vitrification series, there was a significant increase in the blastocyst yield (42.4% vs. 31.3%, P  less then  0.05) when post-warm oocytes were treated with resveratrol. Blastocyst yield from fresh control oocytes was 49%. Levels of reactive oxygen species were comparable between post-warm and fresh control M - II oocytes, and decreased in oocytes after recovery culture with resveratrol. Mitochondrial activity of post-warm oocytes was restored to the pre-vitrification level during the recovery culture regardless of resveratrol supplementation. Thus, short-term recovery culture with resveratrol can rescue bovine M - II oocytes vitrified-warmed on a nylon mesh cryodevice. This paper presents the results of a pilot study of difficult-to-treat patients (exhibiting several previous treatment failures or detection of ESBL strains) with chronic bacterial prostatitis (CBP) who underwent treatment with fosfomycin trometamol (FT) associated with N-acetyl-L-cysteine (NAC). Twenty-eight patients with clinically and microbiologically confirmed CBP, attending a single Urological Institution between January 2018 and March 2019, were treated with oral administration of 3 g FT once a day for two days and then a dose of 3 g every 48 h for two weeks, in combination with oral administration of NAC 600 mg once a day for two weeks. Clinical and microbiological analyses were carried out at the time of admission (T0) and during follow-up at 1 month (T1) and 6 months (T2) after the treatment end. Symptoms were assessed by the NIH Chronic Prostatitis Symptom Index (CPSI) and International Prostatic Symptom Score (IPSS), and quality of life was assessed by Quality of Well-Being (QoL) questionnaires. Isolated strains were Escherichia coli (23 patients), Enterococcus spp. (3 patients), Klebsiella oxytoca (2 patients). ESBL strain was found in 19 patients (67.8%). Microbiological eradication was documented in 21 (75%) patients at the second follow-up visit while clinical cure was reached in 20 (71.4%) patients. Significant changes in terms of questionnaires were recorded between baseline and follow-up visits. Fifteen out of 19 patients (78.9%) with ESBL strains were cured. No significant side effects were reported. Fosfomycin trometamol in combination with N-acetyl-L-cysteine is a promising alternative therapy in difficult-to-treat CBP patients. V.

トップ   新規 一覧 単語検索 最終更新   ヘルプ   最終更新のRSS